Skip to the page

Data / Form D filings / Polyrizon Ltd.

Polyrizon Ltd.: Form D filings

Polyrizon Ltd., a biotechnology company in Raanana, Israel, filed 2 Form D notices with the SEC in 2026. The latest, on September 10, 2026, reports $4 million sold of a $4 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8 HAPNINA STREET, Raanana, Israel, 43215
Phone
+972-9-3740120
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Israel
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1893645

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 10, 2026New notice$3,999,996$3,999,9961Sep 3, 2026sec.gov
Apr 23, 2026New notice$3,499,992$3,499,9921Apr 7, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tomer IzraeliExecutive Officer, DirectorChief Executive Officer and Director
Nir Ben YosefExecutive OfficerChief Financial Officer
Eyal RonExecutive OfficerChief Science Officer
Tidhar TurgemanExecutive OfficerChief Technology Officer
Asaf ItzhaikDirector
Oz AdlerDirector
Liat SidiDirector
Yehonatan Zalman VinokurDirector
Liron CarmelDirector

Every Form D from the week of Sep 7, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Polyrizon Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.